

| Dosage | Package | Price per Dose | Price | ||
|---|---|---|---|---|---|
| 60mg | 56 pill | NZD49.84 | NZD3,489.70 NZD2,791.76 | Best Price Popular | |
| 60mg | 28 pill | NZD59.08 | NZD2,067.81 NZD1,654.25 |
Daklinza, known chemically as daclatasvir, is an oral medication used to treat hepatitis C virus (HCV) infections. It is commonly prescribed in New Zealand as part of a comprehensive treatment plan, often combined with other antiviral medications. Daklinza falls under the class of NS5A inhibitors, which work by preventing the virus from multiplying and spreading within the body. This medication has revolutionized hepatitis C treatment, offering a shorter and more effective therapy option compared to older treatments that involved interferons and ribavirin.
The primary function of Daklinza is to target the NS5A protein, a critical component in the HCV replication cycle. By inhibiting this protein, the virus's ability to reproduce is significantly reduced. This action helps lower the viral load in your bloodstream, allowing your immune system to better control and eliminate the infection. When combined with other antivirals, Daklinza can effectively lead to sustained virologic response (SVR), which is essentially a cure for hepatitis C. It is important to follow your healthcare provider's instructions carefully to ensure the best possible outcome.
In New Zealand, Daklinza is typically prescribed in combination with other medications such as sofosbuvir or other antivirals, depending on the genotype of hepatitis C. The standard dose for adults is usually 60 mg taken once daily with or without food. Your doctor will determine the duration of treatment, which often ranges from 12 to 24 weeks. It is crucial to adhere strictly to the prescribed regimen and complete the full course to maximize effectiveness. Before starting Daklinza, your healthcare provider might perform blood tests to assess liver function and determine if you have any contraindications or potential drug interactions.
Many patients in New Zealand have found Daklinza to be a highly effective and well-tolerated option for hepatitis C treatment. Its once-daily dosing makes it convenient to incorporate into daily routines. The medication has shown high cure rates, especially when used as part of combination therapy tailored to individual patient needs. Additionally, the side effect profile of Daklinza is generally mild, with most side effects being manageable and less severe than older hepatitis C treatments.
While Daklinza is considered safe for most patients, some may experience side effects. Common ones include fatigue, headache, and nausea. Rarely, more serious effects such as allergic reactions or liver issues can occur. It is important to inform your healthcare provider if you notice symptoms like unexplained fatigue, jaundice, or severe abdominal pain. Patients should also disclose all other medications they are taking since certain drugs may interact negatively with Daklinza, reducing its effectiveness or increasing the risk of side effects. Pregnant or breastfeeding women should consult their healthcare provider before starting treatment.
In New Zealand, Daklinza is available through authorized pharmacies with a prescription from a healthcare professional. It is essential to purchase medication from licensed sources to ensure quality and authenticity. Online pharmacies can offer convenience, but caution should be exercised to avoid counterfeit or substandard products. Always verify the legitimacy of the pharmacy and ensure that your healthcare provider's instructions are followed precisely. Proper storage of Daklinza includes keeping it in a cool, dry place away from direct sunlight.
14β21 days. Free from NZD340.89 .
5β9 days. NZD51.13
β10% when paying with cryptocurrency.
β10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.